SIZE XSSIZE SMSIZE MDSIZE LG

HOPA is committed providing high quality education that is strongly integrated with HOPA’s core passion to support pharmacy practitioners and promote and advance Hematology/Oncology Pharmacy to optimize the care of individuals affected by cancer. HOPA strives to become the destination of choice for quality education focused on creating competent hematology/oncology pharmacists with sound domain knowledge, skills and managerial acumen.  Below is the full spectrum of education offerings – you may also sort by content area, date, delivery method, and if it offers BCOP recertification credit.

Biosimilar Integration: Administration’s Considerations

Release date: October 25, 2019
Expiration date: October 25, 2022
ACPE credit must be claimed by: October 25, 2022

Offered On-Demand only.

Register Now

Course Description

This webinar will review the numerous financial, operational, and clinical aspects to consider when implementing biosimilars into oncology care.

Learning Objectives

  • Review the approval and commercialization process of biosimilar medication.
  • Examine biosimilars' impact on marketplace trends.
  • Review various financial, operational, and clinical considerations for the use of biosimilars.
  • Present methods to successfully incorporate biosimilars into oncology workflow.

Speaker

hopa webinar education speaker peter schwieterman

Philip Schwieterman, PharmD MHA

Philip Schwieterman obtained his bachelors and doctorate of pharmacy degrees from The Ohio State University and his Master of Health Administration from the University of Kentucky. Philip joined UK HealthCare as a Pharmacy Director in 2013 where he has led numerous financial, clinical, and operational initiatives surrounding the growth and oversight of oncology, infusion, specialty and pediatric pharmacy services. He currently serves as the Pharmacy Director for Oncology and Pediatrics.

Disclosures

None

Target Audience

This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-19-098-H04-P.

Activity Type

Knowledge

Cost

HOPA Member ‒ $0
Nonmember ‒ $0

Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test. ACPE credit must be claimed by October 25, 2022.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

If you have questions about this webinar, please contact HOPA's Education Support at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Supported by an independent medical education grant from Sandoz Inc., a Novartis Division.

xs
sm
md
lg